13M Americans skip medication due to high prescription cost, survey says
Nearly 13 million Americans skipped or delayed prescribed medicine in the year before the COVID-19 pandemic due to high costs, according to a recent survey.
Some Americans skip buying Christmas presents to afford health care, survey finds
Consumers have skipped spending money on food, travel and even holiday gifts due to health care costs, according to a survey from HealthCareInsider.
After FDA approval, first prescription eye drops to treat blurry near vision hit shelves
Vuity, which should be used once daily in each eye, works in as early as 15 minutes and provide up to 6 hours of sharper vision.
Varney: The political sands are shifting
FOX Business host Stuart Varney discusses Democratic governors retreating from Biden's federal vaccine mandate
Elizabeth Holmes cross-examination wraps
Cross examination of Theranos founder Elizabeth Holmes has wrapped
Pfizer CEO on omicron variant: Booster will be enough to maintain protection
Pfizer CEO Albert Bourla said Wednesday that the company's COVID-19 booster shot would be enough to "maintain protection" against the omicron variant.
Elizabeth Holmes’s testimony: Moments that might influence jurors
Elizabeth Holmes’s surprise turn on the witness stand in her criminal-fraud trial has given jurors a close look at the control she held over her blood-testing startup Theranos Inc., and at the alleged torment she endured in her personal life at the same time.
New international travel testing rules: What to know
The U.S. Centers for Disease Control and Prevention (CDC) announced this week that its international travel requirements have changed.
Supply chain issues impacting pharmacies: What to know
Pharmacies are reportedly running out of important prescription medications, and the U.S. Food and Drug Administration (FDA) shows there are about 111 drugs on backorder – including heart medications, antibiotics and cancer drugs.
Dr. Fauci warns COVID can’t be ‘eradicated’
Dr. Anthony Fauci, in a wide-ranging interview, discusses COVID goals, media criticism and whether he'll step down from his White House position.
FDA aims for quick review of omicron vaccines and drugs
The Food and Drug Administration is laying the groundwork for the rapid review of Omicron-targeted vaccines and drugs if they turn out to be needed, according to people familiar with the matter.
Seniors are losing out on Medicare savings during open enrollment, data shows
The Medicare and Medicare Advantage open enrollment period ends on Dec. 7, but many seniors haven't reviewed their health coverage. Even fewer decided to actually change plans, according to a new survey.
Remdesivir expected to remain effective against omicron variant, Gilead says
After conducting an initial genetic analysis of more than 200 available sequences of the omicron variant, including those from South Africa, Asia and Europe, the biotechnology giant has found no new mutations present in the strain that are expected to alter the viral RNA polymerase compared to previous COVID-19 variants.
States: Sackler family members abusing bankruptcy process
A federal judge should reject a sweeping settlement to thousands of lawsuits against OxyContin maker Purdue Pharma, a group of states said at a hearing Tuesday, arguing that the protections it extends to members of the Sackler family who own the firm are improper.
The Elizabeth Holmes trial: Theranos founder admits regrets, deflects prosecutors
Theranos Inc. founder Elizabeth Holmes conceded Tuesday that she has many regrets about how she responded to criticisms of her blood-testing company, as prosecutors questioned her directly for the first time since they charged her with criminal fraud more than three years ago.
Theranos founder Elizabeth Holmes testifies that Balwani berated, abused her
In tearful and intense testimony, Elizabeth Holmes recounted from the witness stand Monday that she had been raped as a Stanford University student and not long after entered an abusive relationship with the man who would become her top deputy at Theranos Inc.
Moderna, Pfizer, J&J talk omicron response
As COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson & Johnson have outlined their respective strategies to tackle the new strain.
Omicron COVID-19 variant: Moderna announces strategy for addressing new variant
Moderna has announced its strategy for addressing the new Omicron variant of COVID-19
Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain
Pfizer and BioNTech said Friday that a COVID-19 vaccine could be developed and produced within 100 days to counter a "vaccine-escape" variant like B.1.1.529.
CVS completes rollout of time-delay drug safes at 851 Texas pharmacy locations
The safes are designed to prevent pharmacy robberies and the potential for associated diversion of controlled substance medications, such as opioids like oxycodone and hydrocodone.

















